Tumor cell growth inhibition and cell differentiation analysis in a canine mammary tumor cell line (MCM-B2) treated with four chemical reagents

Journal of Veterinary Medical Science

Volumn 71, Issue 11, 2009, Pages 1413-1417

  Watanabe, Manabu ^a   Chen, Iris Yun Ju ^a   Ishikura, Yasuhiro ^a   Nakagawa, Takayuki ^a   Mochizuki, Manabu ^a   Nishimura, Ryohei ^a,b   Sasaki, Nobuo ^a   Sugano, Sumio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

5azaC; Atra; Canine mammary tumor; TPA; TSA

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOG; DOG DISEASE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DOG DISEASES; DOGS; FEMALE; MAMMARY NEOPLASMS, ANIMAL;

ATRA;

EID: 71749085452     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.001413     Document Type: Article

References (32)

1. Brodey, R. S., Goldschmidt, M. A. and Roszel, J. R. 1983. Canine mammary epithelial neoplasms. J. Am. Anim. Hosp. Assoc. 19: 61-90.
2. Butler, L.M., Agus, D.B., Scher, H.I., Higgins, B., Rose, A., Cordon-Cardo, C., Thaler, H.T., Rifkind, R.A., Marks, P.A. and Richon, V.M. 2000. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 60: 5165-5170.
3. Castaigne, S., Chomienne, C., Daniel, M.T., Ballerini, P., Berger, R., Fenaux, P. and Degos, L. 1990. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clini. Res. Blood 76: 1704-1709.
4. Cotchin, E. 1976. Presidential address. Comparative oncology: the veterinary contribution. Proc. R. Soc. Med. 69: 649-656.
5. Egger, G., Liang, G., Aparicio, A. and Jones, P.A. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
6. Furumai, R., Matsuyama, A., Kobashi, N., Lee, K.H., Nishiyama, M., Nakajima, H., Tanaka, A., Komatsu, Y., Nishino, N., Yoshida, M. and Horinouchi, S. 2002. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 62: 4916-4921.
7. Hakami, N., Look, A.T., Steuber, P.C., Krischer, J., Castleberry, R., Harris, R., Ravindranath, Y. and Vietti, T.J. 1987. Combined etoposide and 5-azacitydine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. J. Clin. Oncol. 5: 1022-1025.
8. Hampe, J. F. and Misdrop, W. 1974. Tumors and dysplasias of the mammary gland. Bul. World Health Org. 50: 111-133.
9. Huang, M. E., Ye, Y. C., Chen, S. R., Chai, J. R., Lu J. X., Zhoa, L., Gu, L. J. and Wang, Z. Y. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
10. Issa, J.P., Gharibyan, V., Cortes, J., Jelinek, J., Morris, G., Verstovsek, S., Talpaz, M., Garcia-Manero, G. and Kantarjian, H.M. 2005. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J. Clin. Oncol. 23: 3948-3956.
11. Ito, Y., Kawanishi, M., Harayama, T. and Takabayashi, S. 1981. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Cancer Lett. 12: 175-180.
12. MacEwen, E. G. and Withrow, S. J. 1989. Tumors of the mammary gland. pp. 292-304. In: Clin. Vet. Oncol. Philadelphia, J. B. Lippincott.
13. MacEwen, E. G. 1990. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Meta. Rev. 9: 125-136.
14. Minucci, S. and Pelicci, P.G. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6: 38-51.
15. Miyajima, N., Watanabe, M., Ohashi, E., Mochizuki, M., Nishimura, R., Ogawa, H., Sugano, S. and Sasaki, N. 2006. Relationship between retinoic acid receptor alpha gene expression and growth-inhibitory effect of all-trans retinoic acid on canine tumor cells. J. Vet. Intern. Med. 20: 348-354.
16. Mottolese, M., Morelli, L., Agrimi, U., Benevolo, M., Sciarretta, F., Antonucci, G. and Natali, P. G. 1994. Spontaneous canine mammary tumors. A model for monoclonal antibody diagnosis and treatment of human breast cancer. Lab. Invest. 71: 182-187.
17. Moulton, J.E., Rosenblatt, L.S. and Goldman, M. 1986. Mammary tumors in a colony of beagle dogs. Vet. Pathol. 23: 741-749.
18. Olszewska, M.J., Gernand, D. and Sakowicz, T. 1999. Methylation sensitive restriction endonuclease digestion patterns revealed in Vicia faba L. chromosomes by in situ nick-translation. Folia. Histochem. Cytobiol. 37: 267-274.
19. Priester, W. A. 1979. Occurence of mammary neoplasm in bitches in relation to breed, age, tumor type and geographical region from which reported. J. Small. Anim. Pract. 20: 1-11.
20. Priosoeryanto, B. P., Tateyama, S., Yamaguchi, R. and Uchida, K. 1995. Establishment of a cell line (MCM-B2) from a benign mixed tumour of canine mammary gland. Res. Vet. Sci. 58: 272-276.
21. Priosoeryanto, B. P., Tateyama, S., Yamaguchi, R. and Uchida, K. 1995. Transplantation of a cell line derived from a canine benign mixed mammary tumour into nude mice. J. Comp. Pathol. 113: 383-388.
22. Roh, M.S., Kim, C.W., Park, B.S., Kim, G.C., Jeong, J.H., Kwon, H.C., Suh, D.J., Cho, K.H., Yee, S.B. and Yoo, Y.H. 2004. Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells. Apoptosis 9: 583-589.
23. Sachs, L. 1991. Opening remarks. A visionary assessment of the scientific, clinical, and economic implications of hematopoietic growth factors. Cancer 67: 2681-2683.
24. Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T. and Nakanishi, O. 1999. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. U.S.A. 96: 4592-4597.
25. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H. and Sakai, T. 1997. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241: 142-150.
26. Takauji, S.R., Watanabe, M., Uyama, R., Nakagawa, T., Miyajima, N., Mochizuki, M., Nishimura, R., Sugano, S. and Sasaki, N. 2007. Expression and subcellular localization of E-cadherin, a-catenin, and b-catenin in 8 feline mammary tumor cell lines. J. Vet. Med. Sci. 69: 831-834.
27. Warrell, R. P. Jr., Frankel, S. R., Miller, W. H. Jr., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A. and Jakubowski, A. 1991. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-transretinoic acid). New Engl. J. Med. 324: 1385-1393.
28. Watanabe, M., Sugano, S., Imai, J., Yoshida, K., Onodera, R., Amin, M.R., Uchida, K., Yamaguchi, R. and Tateyama, S. 2001. Inhibition of cell proliferation, suppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM-B2 by sodium phenylacetate. Res. Vet. Sci. 70: 27-32.
29. Watanabe, M., Miyajima, N., Igarashi, M., Endo, Y., Watanabe, N. and Sugano, S. 2008. Sodium Phenylacetate inhibits the Ras/ MAPK signaling pathway to induce reduction of c-Raf-1 protein in human and canine breast cancer cells. Breast Cancer Res. Treat. (in press)
30. Yamashita, K., Upadhyay, S., Osada, M., Hoque, M.O., Xiao, Y., Mori, M., Sato, F., Meltzer, S.J. and Sidransky, D. 2002. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2: 485-495.
31. Yoo, C.B. and Jones, P.A. 2006. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug. Discov. 5: 37-50.
32. Yoshida, M., Kijima, M., Akita, M. and Beppu, T. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265: 17174-17179.